A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...
For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...
Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with ...
The majority of infections in multiple sclerosis (MS) are reported in non-neurology practices, according to study results presented at the European Committee for Treatment and Research in Multiple ...
In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
Everyday Health on MSN
6 Frequently Asked Questions About Inactive Secondary-Progressive MS, Answered
Having inactive secondary progressive multiple sclerosis can be confusing. Relapses may stop, but symptoms persist. Get ...
Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback